General Discussion
In reply to the discussion: Interesting re Erika Kirk [View all]Clouds Passing
(7,646 posts)After the Epstein files exposed that the New Mexico ranch he called Zorro Ranch was operating baby factories and other crimes probably worse than Epstein Island, people did some investigating. The new owner is Don Huffines (a Texas businessman, former Republican state senator, current candidate for Texas state comptroller, and self-described MAGA Trump Republican).
Huffines family purchased the property in 2023 through an LLC called San Rafael Ranch LLC (later renamed Rancho de San Rafael in some records) at a public auction four years after Epsteins death, with proceeds reportedly benefiting victims. Huffines campaign has stated the family had never visited prior to the listing and plans to use it as a Christian retreat or similar.
Secretome Therapeutics develops regenerative therapies using neonatal cardiac progenitor cells (nCPCs)specifically, cells from discarded tissue during lifesaving heart surgeries on newborns/infants with congenital heart defects (ethically sourced medical waste, regulated under IRB/FDA guidelines, similar to other neonatal stem cell sources like cord blood or umbilical tissue in the field). Their lead product, STM-01, is a cellular therapy that harnesses the cells secretome (secreted proteins, exosomes, factors) to reduce inflammation, inhibit fibrosis, and promote heart repair. Its in Phase 1 trials for conditions like heart failure with preserved ejection fraction (HFpEFfirst patient dosed in 2025, FDA Fast Track granted March 2025) and dilated cardiomyopathy (DCM), with plans for more. The company raised $20.4 million in late 2024 to fund trials and pipeline expansion (total funding ~$32M+ per some profiles). It is not publicly tradedits a private company (no stock on Nasdaq/NYSE, no IPO announced as of now), venture-backed with investors including HEST and others.
https://greerjournal.com/exclusive-the-fda-investigates-don-huffines-the-new-owner-of-epsteins-new-mexico-ranch/
.